Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Perkins

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 15, 2011
Diagnostics as essential tools for containing antibacterial resistanceIruka N Okeke, Rosanna W Peeling, Herman Goossens, et al.
Nature|December 13, 2006
Reducing the global burden of tuberculosis: the contribution of improved diagnosticsEmmett Keeler, Mark D Perkins, Peter Small, et al.
The Lancet. Microbe|August 28, 2023
Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variantsNathalie Worp, Lorenzo Subissi, Mark D Perkins, et al.
The Journal of Infectious Diseases|May 2, 2013
Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in UgandaHeidi Hopkins, Iveth J González, Spencer D Polley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2008
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countriesCarlos Acuna-Villaorduna, Anna Vassall, German Henostroza, et al.
The Journal of Infectious Diseases|March 14, 2015
Target product profile of a molecular drug-susceptibility test for use in microscopy centersClaudia M Denkinger, David Dolinger, Marco Schito, et al.
Nature Genetics|January 9, 2023
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programsAlvin X Han, Amy Toporowski, Jilian A Sacks, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programsAlvin X Han, Amy Toporowski, Jilian A Sacks, et al.
The Journal of Infectious Diseases|March 14, 2015
Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosisHugh Salamon, Ken D Yamaguchi, Daniela M Cirillo, et al.
Plos One|September 12, 2009
Implications of storing urinary DNA from different populations for molecular analysesAngela Cannas, Glendah Kalunga, Clare Green, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 15, 2011
Diagnostics as essential tools for containing antibacterial resistanceIruka N Okeke, Rosanna W Peeling, Herman Goossens, et al.
Nature|December 13, 2006
Reducing the global burden of tuberculosis: the contribution of improved diagnosticsEmmett Keeler, Mark D Perkins, Peter Small, et al.
The Lancet. Microbe|August 28, 2023
Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variantsNathalie Worp, Lorenzo Subissi, Mark D Perkins, et al.
The Journal of Infectious Diseases|May 2, 2013
Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in UgandaHeidi Hopkins, Iveth J González, Spencer D Polley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2008
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countriesCarlos Acuna-Villaorduna, Anna Vassall, German Henostroza, et al.
The Journal of Infectious Diseases|March 14, 2015
Target product profile of a molecular drug-susceptibility test for use in microscopy centersClaudia M Denkinger, David Dolinger, Marco Schito, et al.
Nature Genetics|January 9, 2023
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programsAlvin X Han, Amy Toporowski, Jilian A Sacks, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programsAlvin X Han, Amy Toporowski, Jilian A Sacks, et al.
The Journal of Infectious Diseases|March 14, 2015
Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosisHugh Salamon, Ken D Yamaguchi, Daniela M Cirillo, et al.
Plos One|September 12, 2009
Implications of storing urinary DNA from different populations for molecular analysesAngela Cannas, Glendah Kalunga, Clare Green, et al.
Pageof 6